Josh Sharfstein

Professor of the Practice

19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Josh Sharfstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
United States Food and Drug Administration Medicine & Life Sciences
Public Health Medicine & Life Sciences
Health Medicine & Life Sciences
Delivery of Health Care Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Health Policy Medicine & Life Sciences
Politics Medicine & Life Sciences
Hospital Economics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products

Rollman, J. E., Heyward, J., Olson, L., Lurie, P., Sharfstein, J. & Alexander, G. C., Feb 19 2019, In : JAMA - Journal of the American Medical Association. 321, 7, p. 676-685 10 p.

Research output: Contribution to journalArticle

Fentanyl
United States Food and Drug Administration
Pharmacists
Opioid Analgesics
Insurance Claim Review
Open Access
Motor Vehicles
Health Status
Public Health
Obesity
Smoking

Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities

Pytell, J. D., Sharfstein, J. M. & Olsen, Y., Jan 1 2019, (Accepted/In press) In : JAMA internal medicine.

Research output: Contribution to journalComment/debate

Skilled Nursing Facilities
Methadone

Introduction: State Innovation Models

Sharfstein, J., Jan 1 2019, In : Milbank Quarterly.

Research output: Contribution to journalArticle

Lessons Learned from the Opioid Epidemic

Sharfstein, J. & Olsen, Y., Sep 3 2019, In : JAMA - Journal of the American Medical Association. 322, 9, p. 809-810 2 p.

Research output: Contribution to journalShort survey

Open Access
Opioid Analgesics